184 related articles for article (PubMed ID: 35881322)
1. The Discovery of Anti-Yo (Anti-PCA1) Antibody in Patients with Paraneoplastic Cerebellar Degeneration: Opening a Window into Autoimmune Neurological Disease.
Greenlee JE; Brashear HR
Cerebellum; 2023 Aug; 22(4):531-533. PubMed ID: 35881322
[TBL] [Abstract][Full Text] [Related]
2. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.
Panja D; Vedeler CA; Schubert M
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):141-156. PubMed ID: 29679372
[TBL] [Abstract][Full Text] [Related]
4. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
[TBL] [Abstract][Full Text] [Related]
5. Cerebellar leptomeningeal enhancement: An imaging finding of rapidly progressive Purkinje cell cytoplasmic autoantibody type 1 paraneoplastic cerebellar syndrome.
Thakolwiboon S; Linnoila J; Pittock SJ; Dubey D; Zekeridou A
J Neuroimmunol; 2024 Feb; 387():578293. PubMed ID: 38266443
[TBL] [Abstract][Full Text] [Related]
6. A Pilot Study to Develop Paraneoplastic Cerebellar Degeneration Mouse Model.
Faure F; Yshii L; Renno T; Coste I; Joubert B; Desestret V; Liblau R; Honnorat J
Cerebellum; 2024 Feb; 23(1):181-196. PubMed ID: 36729270
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review on Anti-Yo/PCA-1 Antibody: Beyond Cerebellar Ataxia in Middle-Aged Women with Gynecologic Cancer.
Mendes NT; Ronchi NR; Silva GD
Cerebellum; 2023 Dec; 22(6):1287-1292. PubMed ID: 36334195
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic neurologic syndrome associated with gynecologic and breast malignancies.
Peter E; Honnorat J; Desestret V
Handb Clin Neurol; 2024; 200():409-417. PubMed ID: 38494293
[TBL] [Abstract][Full Text] [Related]
10. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
[TBL] [Abstract][Full Text] [Related]
11. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
Tanaka M; Tanaka K; Onodera O; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):95-100. PubMed ID: 7788981
[TBL] [Abstract][Full Text] [Related]
12. Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.
Yshii L; Bost C; Liblau R
Front Immunol; 2020; 11():991. PubMed ID: 32655545
[TBL] [Abstract][Full Text] [Related]
13. Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures.
Greenlee JE; Clawson SA; Hill KE; Wood BL; Tsunoda I; Carlson NG
J Neuropathol Exp Neurol; 2010 Oct; 69(10):997-1007. PubMed ID: 20838245
[TBL] [Abstract][Full Text] [Related]
14. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
[TBL] [Abstract][Full Text] [Related]
15. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.
Meglic B; Graus F; Grad A
J Neurol Sci; 2001 Apr; 185(2):135-8. PubMed ID: 11311295
[TBL] [Abstract][Full Text] [Related]
16. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
[TBL] [Abstract][Full Text] [Related]
17. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
18. Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder: detection of Yo antigen in tumor tissue and fall in antibody titers following tumor removal.
Greenlee JE; Dalmau J; Lyons T; Clawson S; Smith RH; Pirch HR
Ann Neurol; 1999 Jun; 45(6):805-9. PubMed ID: 10360776
[TBL] [Abstract][Full Text] [Related]
19. [Autoimmune paraneoplastic cerebellar degeneration].
Lövblad KO; Henny C; Boucraut J; Graus F; Delaloye JF; Bernard D; Steck AJ; Regli F
Rev Neurol (Paris); 1994; 150(1):46-9. PubMed ID: 7801040
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma.
Greenlee JE; Brashear HR
Ann Neurol; 1983 Dec; 14(6):609-13. PubMed ID: 6360029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
